Targeted Inhibition of mRNA Translation Initiation Factors as a Novel Therapeutic Strategy for Mature B-Cell Neoplasms

doi 10.37349/etat.2020.00002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Exploration Publishing

Related search

Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation

Trends in Pharmacological Sciences
ToxicologyPharmacology
2014English

Inhibition of C-Met Is a Potential Therapeutic Strategy for Treatment of Diffuse Large B-Cell Lymphoma

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

Targeted Inhibition of Pancreatic Acinar Cell Calcineurin Is a Novel Strategy to Prevent Post-Ercp Pancreatitis

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies

OncoImmunology
OncologyAllergyImmunology
2013English

Translation Initiation of the HIV-1 mRNA

Translation
BiochemistryDevelopmental BiologyCell BiologyMolecular Biology
2014English

Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

P1.03-13 eIF2β, a Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy